Roberto Guerciolini is now chief medical officer of Skyhawk Therapeutics. Guerciolini’s experience includes posts at Wave Life Sciences (NASDAQ: WVE), SIRNA Therapeutics, and Dicerna Pharmaceuticals (NASDAQ: DRNA). Waltham, MA-based Skyhawk is developing RNA-targeting drugs to treat cancer and neurological diseases. Skyhawk launched a little more than a year ago; last June, the company landed a […]
Original Article: Skyhawk Therapeutics Appoints Guerciolini Chief Medical Officer